Clinical Trial: A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy

U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07124078) titled 'A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy' on Aug. 08.

Brief Summary: This study will be conducted to compare Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy.

Study Start Date: Dec. 15, 2025

Study Type: INTERVENTIONAL

Condition: Chronic Graft-versus-host-disease

Intervention: DRUG: INCA034176

Axatilimab at the protocol-defined dose.

DRUG: Best available Treatment (BAT)

Best Available Ther...